Education
About Us
Working with TipRanks
Follow Us
Vimian Group AB (DE:0V0)
FRANKFURT:0V0
0V0 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€2.43 - €4.16
Previous CloseN/A
Volume0.00
Average Volume (3M)237.00
Market Cap
€1.78B
Enterprise Value€22.86B
Total Cash (Recent Filing)-€12.04M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)93.4
Beta0.57
Next Earnings
Apr 29, 2025EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding517,895,100
10 Day Avg. Volume0
30 Day Avg. Volume237
Financial Highlights & Ratios
PEG Ratio1.16
Price to Book (P/B)N/A
Price to Sales (P/S)4.84
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.23Price Target Upside24.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
---
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceVimian's 4Q24 exceeded expectations, with net sales up 27% year-over-year to EUR 104.9m, driven by strong double-digit increases in Specialty Pharma, Veterinary Services, and Diagnostics.
Market ListingThe Listing Committee of Nasdaq Stockholm approved Vimian's application to be listed on the Nasdaq Stockholm Main Market in the Large Cap segment, which is expected to improve liquidity in the shares and elevate the company's profile.
Bears Say
EBITA Margin DeclineThe adj. EBITA margin was 23.4%, down from 27.5%, reflecting the effects of R&D capitalization, a write-off in Specialty Pharma, and investments in marketing and sales.
MedTech Segment ChallengesMedTech experienced modest growth of 4%, influenced by ongoing challenges in the US surgery market.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.51%
Mutual Funds
― Other Institutional Investors
94.90% Public Companies and
Individual Investors
0V0 FAQ
What was Vimian Group AB’s price range in the past 12 months?
Vimian Group AB lowest stock price was €2.42 and its highest was €4.16 in the past 12 months.
What is Vimian Group AB’s market cap?
Vimian Group AB’s market cap is €1.78B.
When is Vimian Group AB’s upcoming earnings report date?
Vimian Group AB’s upcoming earnings report date is Apr 29, 2025 which is in 6 days.
How were Vimian Group AB’s earnings last quarter?
Vimian Group AB released its earnings results on Feb 13, 2025. The company reported €0.027 earnings per share for the quarter, beating the consensus estimate of €0.024 by €0.003.
Is Vimian Group AB overvalued?
According to Wall Street analysts Vimian Group AB’s price is currently Undervalued.
Does Vimian Group AB pay dividends?
Vimian Group AB does not currently pay dividends.
What is Vimian Group AB’s EPS estimate?
Vimian Group AB’s EPS estimate is 0.02.
How many shares outstanding does Vimian Group AB have?
Vimian Group AB has 517,895,100 shares outstanding.
What happened to Vimian Group AB’s price movement after its last earnings report?
Vimian Group AB reported an EPS of €0.027 in its last earnings report, beating expectations of €0.024. Following the earnings report the stock price went up 1.466%.
Which hedge fund is a major shareholder of Vimian Group AB?
Currently, no hedge funds are holding shares in DE:0V0
---
Company Description
Vimian Group AB
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology and specialised nutrition.
---
0V0 Stock 12 Month Forecast
Average Price Target
€4.23
▲(24.05% Upside)
Technical Analysis
Elekta AB
―
Vitrolife AB
―
AddLife AB
―
BONESUPPORT HOLDING AB
―
Prostatype Genomics AB
―
Best Analysts Covering 0V0
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
+22.01%
reiterated a buy rating last month
Copying Adela Dashian's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +22.01% per trade.
---